By Josh White
Date: Wednesday 22 Oct 2025
(Sharecast News) - Novacyt said on Wednesday that it expects improved second-half performance in 2025, as it outlined a new growth strategy focused on accelerating product development, achieving sustained double-digit revenue growth, and returning to EBITDA profitability.
By Josh White
Date: Friday 12 Sep 2025
(Sharecast News) - Novacyt said on Friday that its Lab 21 Healthcare subsidiary has been fined £52,000 following the conclusion of a Health and Safety Executive prosecution relating to historical operations at its former Axminster site.
By Josh White
Date: Thursday 30 Jan 2025
(Sharecast News) - Novacyt reported strong revenue growth for 2024 in an update on Thursday, with unaudited statutory revenue reaching about £19.6m, an 85% increase from the prior year's £10.6m.
| Currency | UK Pounds |
| Share Price | 39.10p |
| Change Today | 1.65p |
| % Change | 4.41 % |
| 52 Week High | 62.10 |
| 52 Week Low | 37.00 |
| Volume | 149,664 |
| Shares Issued | 70.63m |
| Market Cap | £27.61m |
| RiskGrade | 453 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:22 | 1,500 @ 38.50p |
| 16:22 | 1,500 @ 38.50p |
| 15:41 | 1,500 @ 39.42p |
| 15:28 | 3,856 @ 38.91p |
| 15:18 | 3 @ 38.50p |
You are here: research